Physician profile
William E Katz
NPI 1013981588
$7,756.01
in general payments reported to CMS, 2019-2025
7 companies · $2,387 in 2025
The $2,387 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $759 · 2021: $1,086 · 2022: $49.30 · 2023: $1,684 · 2024: $1,037 · 2025: $2,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,123 · Food and Beverage: $1,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,122.95 |
| Food and Beverage | $1,985.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,804.15 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $1,724.74 | 2025 | Evoque |
| Boston Scientific Corporation | $125.53 | 2019 | |
| Philips North America LLC | $31.07 | 2025 | Igt Devices Undivided |
| Medtronic, INC. | $25.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.56 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $20.51 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.